Pricing
Login
Home
Charts
Search
Watchlist
Products

Alivus Life Sciences Ltd

ALIVUS
₹1,436.90-0.90%20 Nov 2026
Reports
Pharma API

Alivus Life Sciences Ltd

ALIVUS
₹1,436.90
-0.90%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹17,669Cr
Close
Close Price
₹1,436.90
Industry
Industry
Pharma API
PE
Price To Earnings
26.35
PS
Price To Sales
6.58
Revenue
Revenue
₹2,684Cr
Rev Gr TTM
Revenue Growth TTM
8.19%
PAT Gr TTM
PAT Growth TTM
26.27%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
573537589507642650602588673689640682
Growth YoY
Revenue Growth YoY%
5.9-13.61.8-14.912.121.12.316.04.86.16.416.0
Expenses
ExpensesCr
400395429373452451430409442475429417
Operating Profit
Operating ProfitCr
173141159134190198172179231215212265
OPM
OPM%
30.126.427.126.529.630.628.630.534.431.133.138.9
Other Income
Other IncomeCr
23591010915-12232220
Interest Expense
Interest ExpenseCr
000001111111
Depreciation
DepreciationCr
131514151516171820202122
PBT
PBTCr
161130150127185191163174198216212262
Tax
TaxCr
423239324849414448535265
PAT
PATCr
1199811195137142122130150163160197
Growth YoY
PAT Growth YoY%
13.1-33.1-17.7-19.715.344.99.036.49.714.731.751.3
NPM
NPM%
20.718.318.918.821.321.820.222.122.323.625.028.9
EPS
EPS₹
9.78.09.17.811.211.69.910.612.313.213.016.0
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
573537589507642650602588673689640682
Growth YoY
Revenue Growth YoY%
5.9-13.61.8-14.912.121.12.316.04.86.16.416.0
Expenses
ExpensesCr
400395429373452451430409442475429417
Operating Profit
Operating ProfitCr
173141159134190198172179231215212265
OPM
OPM%
30.126.427.126.529.630.628.630.534.431.133.138.9
Other Income
Other IncomeCr
23591010915-12232220
Interest Expense
Interest ExpenseCr
000001111111
Depreciation
DepreciationCr
131514151516171820202122
PBT
PBTCr
161130150127185191163174198216212262
Tax
TaxCr
423239324849414448535265
PAT
PATCr
1199811195137142122130150163160197
Growth YoY
PAT Growth YoY%
13.1-33.1-17.7-19.715.344.99.036.49.714.731.751.3
NPM
NPM%
20.718.318.918.821.321.820.222.122.323.625.028.9
EPS
EPS₹
9.78.09.17.811.211.69.910.612.313.213.016.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
08861,5371,8852,1232,1612,2832,3872,5522,684
Growth
Revenue Growth%
3,57,327.873.422.612.61.85.64.56.98.2
Expenses
ExpensesCr
06391,0651,2941,5071,5191,6091,7041,7551,762
Operating Profit
Operating ProfitCr
0248472591616642674683797923
OPM
OPM%
-5.227.930.731.429.029.729.528.631.234.4
Other Income
Other IncomeCr
00121152912353553
Interest Expense
Interest ExpenseCr
0134882812255
Depreciation
DepreciationCr
0192933384253617582
PBT
PBTCr
0228421471565629631654751888
Tax
TaxCr
033108119146162160169187219
PAT
PATCr
0196313352419467471486564670
Growth
PAT Growth%
45,167.360.112.319.111.50.83.116.226.3
NPM
NPM%
-175.022.120.418.619.721.620.620.422.124.9
EPS
EPS₹
-7.924.629.032.635.638.138.439.646.054.5
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
08861,5371,8852,1232,1612,2832,3872,5522,684
Growth
Revenue Growth%
3,57,327.873.422.612.61.85.64.56.98.2
Expenses
ExpensesCr
06391,0651,2941,5071,5191,6091,7041,7551,762
Operating Profit
Operating ProfitCr
0248472591616642674683797923
OPM
OPM%
-5.227.930.731.429.029.729.528.631.234.4
Other Income
Other IncomeCr
00121152912353553
Interest Expense
Interest ExpenseCr
0134882812255
Depreciation
DepreciationCr
0192933384253617582
PBT
PBTCr
0228421471565629631654751888
Tax
TaxCr
033108119146162160169187219
PAT
PATCr
0196313352419467471486564670
Growth
PAT Growth%
45,167.360.112.319.111.50.83.116.226.3
NPM
NPM%
-175.022.120.418.619.721.620.620.422.124.9
EPS
EPS₹
-7.924.629.032.635.638.138.439.646.054.5
Sales CAGR
1 Year7%
3 Years6%
5 Years6%
TTM8%
EBITDA CAGR
1 Year17%
3 Years7%
5 Years6%
TTM25%
PAT CAGR
1 Year16%
3 Years7%
5 Years10%
TTM26%
Avg. ROCE
1 Year22%
3 Years24%
5 Years26%
TTM25%
CFO / EBITDA
1 Year71%
3 Years64%
5 Years67%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
0222252525252525
Reserves
ReservesCr
-1864007512,0302,1142,3082,7933,3083,607
Current Liabilities
Current LiabilitiesCr
11,3801,3071,221384497439470508564
Non Current Liabilities
Non Current LiabilitiesCr
071623336779124143147
Total Liabilities
Total LiabilitiesCr
01,4751,7261,9972,4712,7022,8503,4113,9834,342
Current Assets
Current AssetsCr
09311,1601,3991,7651,8501,9162,3352,6492,865
Non Current Assets
Non Current AssetsCr
05455655987068529341,0761,3341,477
Total Assets
Total AssetsCr
01,4751,7261,9972,4712,7022,8503,4113,9834,342
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
0222252525252525
Reserves
ReservesCr
-1864007512,0302,1142,3082,7933,3083,607
Current Liabilities
Current LiabilitiesCr
11,3801,3071,221384497439470508564
Non Current Liabilities
Non Current LiabilitiesCr
071623336779124143147
Total Liabilities
Total LiabilitiesCr
01,4751,7261,9972,4712,7022,8503,4113,9834,342
Current Assets
Current AssetsCr
09311,1601,3991,7651,8501,9162,3352,6492,865
Non Current Assets
Non Current AssetsCr
05455655987068529341,0761,3341,477
Total Assets
Total AssetsCr
01,4751,7261,9972,4712,7022,8503,4113,9834,342

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
010195388598306414392565
Investing Cash Flow
Investing Cash FlowCr
0-9-51-69-122-147-116-616-570
Financing Cash Flow
Financing Cash FlowCr
01-137-214-79-388-279-6-64
Net Cash Flow
Net Cash FlowCr
028106397-22818-230-69
Free Cash Flow
Free Cash FlowCr
01144322466143285226259
CFO To PAT
CFO To PAT%
110.85.362.3110.4142.765.587.880.6100.2
CFO To EBITDA
CFO To EBITDA%
3,700.04.241.365.797.047.661.357.470.9
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
010195388598306414392565
Investing Cash Flow
Investing Cash FlowCr
0-9-51-69-122-147-116-616-570
Financing Cash Flow
Financing Cash FlowCr
01-137-214-79-388-279-6-64
Net Cash Flow
Net Cash FlowCr
028106397-22818-230-69
Free Cash Flow
Free Cash FlowCr
01144322466143285226259
CFO To PAT
CFO To PAT%
110.85.362.3110.4142.765.587.880.6100.2
CFO To EBITDA
CFO To EBITDA%
3,700.04.241.365.797.047.661.357.470.9

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,6244,7989,50013,22911,95717,669
Price To Earnings
Price To Earnings
13.410.320.227.221.226.4
Price To Sales
Price To Sales
2.62.24.25.54.76.6
Price To Book
Price To Book
2.72.24.14.73.64.9
EV To EBITDA
EV To EBITDA
8.37.013.719.415.119.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
66.147.344.843.841.442.845.544.246.946.9
OPM
OPM%
-5.227.930.731.429.029.729.528.631.234.4
NPM
NPM%
-175.022.120.418.619.721.620.620.422.124.9
ROCE
ROCE%
0.9259.7113.274.228.829.226.922.822.324.6
ROE
ROE%
31.0221.977.946.720.421.820.217.216.918.4
ROA
ROA%
-510.613.318.117.616.917.316.514.214.215.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,6244,7989,50013,22911,95717,669
Price To Earnings
Price To Earnings
13.410.320.227.221.226.4
Price To Sales
Price To Sales
2.62.24.25.54.76.6
Price To Book
Price To Book
2.72.24.14.73.64.9
EV To EBITDA
EV To EBITDA
8.37.013.719.415.119.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
66.147.344.843.841.442.845.544.246.946.9
OPM
OPM%
-5.227.930.731.429.029.729.528.631.234.4
NPM
NPM%
-175.022.120.418.619.721.620.620.422.124.9
ROCE
ROCE%
0.9259.7113.274.228.829.226.922.822.324.6
ROE
ROE%
31.0221.977.946.720.421.820.217.216.918.4
ROA
ROA%
-510.613.318.117.616.917.316.514.214.215.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr17,68917,66916,60811,47010,2728,9845,751
Close PriceClose₹462.301,436.90849.15548.201,598.60990.70960.40
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE372.8226.3549.9541.0375.8034.99134.70
Price To SalesPS8.586.589.029.8011.824.164.71
RevenueRevenueCr2,0632,6841,8421,1708692,1611,221
Revenue Growth TTMRev Gr TTM%-21.3%8.2%37.3%4.0%13.4%20.1%
PAT Growth TTMPAT Gr TTM%-101.5%26.3%142.2%-13.6%7.1%16.5%
Market CapitalizationMkt CapCr17,68917,66916,60811,47010,2728,9845,751
Close PriceClose₹462.301,436.90849.15548.201,598.60990.70960.40
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE372.8226.3549.9541.0375.8034.99134.70
Price To SalesPS8.586.589.029.8011.824.164.71
RevenueRevenueCr2,0632,6841,8421,1708692,1611,221
Revenue Growth TTMRev Gr TTM%-21.3%8.2%37.3%4.0%13.4%20.1%
PAT Growth TTMPAT Gr TTM%-101.5%26.3%142.2%-13.6%7.1%16.5%
Interviews